PMC:7291971 / 757-916 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T14","span":{"begin":36,"end":46},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T15","span":{"begin":112,"end":115},"obj":"GO:0008541"},{"id":"T16","span":{"begin":138,"end":143},"obj":"NCBITaxon:10239"},{"id":"T50627","span":{"begin":36,"end":46},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T65425","span":{"begin":112,"end":115},"obj":"GO:0008541"},{"id":"T87174","span":{"begin":138,"end":143},"obj":"NCBITaxon:10239"}],"text":"emotherapy. We designed bisubstrate inhibitors by mimicking the transition state of the 2′-O-methylation of the cap RNA in order to block viral 2′-O MTases. Th"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":116,"end":119},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"emotherapy. We designed bisubstrate inhibitors by mimicking the transition state of the 2′-O-methylation of the cap RNA in order to block viral 2′-O MTases. Th"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":36,"end":46},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"emotherapy. We designed bisubstrate inhibitors by mimicking the transition state of the 2′-O-methylation of the cap RNA in order to block viral 2′-O MTases. Th"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":93,"end":104},"obj":"http://purl.obolibrary.org/obo/GO_0032259"}],"text":"emotherapy. We designed bisubstrate inhibitors by mimicking the transition state of the 2′-O-methylation of the cap RNA in order to block viral 2′-O MTases. Th"}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":12,"end":156},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"emotherapy. We designed bisubstrate inhibitors by mimicking the transition state of the 2′-O-methylation of the cap RNA in order to block viral 2′-O MTases. Th"}